1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ARTIFICIAL ORGAN AND BIONICS MARKET, BY PRODUCT
5.1. Introduction
5.2. Artificial Organ
5.3. Artificial Bionics
6. ARTIFICIAL ORGAN AND BIONICS MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Mechanical Bionics
6.3. Electronic Bionics
7. ARTIFICIAL ORGAN AND BIONICS MARKET, BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Others
8. ARTIFICIAL ORGAN AND BIONICS MARKET, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Zimmer Biomet
10.2. Medtronic
10.3. Abiomed Inc.
10.4. Sonova
10.5. Boston Scientific Corporation
10.6. Ekso Bionics
10.7. Edward Lifesciences Corporation
10.8. Berlin Heart
10.9. SynCardia